tirzepatide' Tirzepatide enhances weight loss with sustained treatment but discontinuation leads to weight regain 1 and GIP therapy Maintenance therapy on semaglutide or

doi:10.2337/db24-791-P 58

They are required for CGMP commercial manufacturing

This helps maintain the stability and potency of the active ingredients for up to 24 months

That slower pace includes delayed stomach emptying and reduced small intestine transit

Several factors contribute to these elevated costs: Patent protection Most GLP-1 medications are still under patent, preventing generic competition Manufacturing complexity These are biologic medications that require specialized production processes Research and development costs Pharmaceutical companies invest heavily in clinical trials and regulatory approval Market positioning These medications are often priced as premium treatments Without insurance coverage, patients face the full retail price, which can make these medications financially inaccessible for many people who need them